Expression of microRNA-155 precursor in peripheral blood mononuclear cells from hepatitis C patients after antiviral treatment

Acta Virologica

Volumn 54, Issue 1, 2010, Pages 75-78

  Sidorkiewicz, M ^a   Grek, M ^a   Jozwiak, B ^a   Majda Stanislawska, E ^a   Piekarska, A ^a   Bartkowiak, J ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Antiviral treatment; BIC; Hepatitis C virus; Microrna 155; Peripheral blood mononuclear cells

Indexed keywords

ALPHA INTERFERON; MESSENGER RNA; MICRORNA; MICRORNA 155 PRECURSOR; RIBAVIRIN; RNA PRECURSOR; UNCLASSIFIED DRUG; VIRUS RNA; ALPHA2B INTERFERON; ANTIVIRUS AGENT; MIRN155 MICRORNA, HUMAN;

ADOLESCENT; ADULT; ANTIVIRAL THERAPY; ARTICLE; CHILD; CONTROLLED STUDY; GENE EXPRESSION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PERSISTENT VIRUS INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; VIRUS DETECTION; BLOOD; DRUG COMBINATION; DRUG EFFECT; GENETICS; METABOLISM; MONONUCLEAR CELL; TREATMENT OUTCOME; VIROLOGY;

HEPATITIS C VIRUS;

ADOLESCENT; ANTIVIRAL AGENTS; CHILD; DRUG THERAPY, COMBINATION; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; LEUKOCYTES, MONONUCLEAR; MICRORNAS; RIBAVIRIN; RNA PRECURSORS; RNA, VIRAL; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77952308402     PISSN: 0001723X     EISSN: None     Source Type: Journal    
DOI: 10.4149/av_2010_01_75     Document Type: Article

References (24)

1. Baré P, Massud I, Parodi C, Belmonte L, García G, Nebel MC, Corti M, Pinto MT, Bianco RP, Bracco MM, Campos R, Ares BR. (2005) Continuous release of hepatitis C virus (HCV) by peripheral blood mononuclear cells and B-lymphoblastoid cell-line cultures derived from HCV-infected patients. J. Gen. Virol. 86, 1717-1727.
2. Bartel DP. (2004) MicroRNAs target recognition and regulatory functions. Cell 116, 281-297.
3. Blackard JT, Kemmer N, Sherman KE. (2006) Extrahepatic replication of HCV insights into clinical manifestations and biological consequences. Hepatology 44, 15-22.
4. Chomczynski P, Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal. Biochem. 162, 156-159.
5. Craxì A, Laffi G, Zignego AL. (2008) Hepatitis C virus (HCV) infection a systemic disease. Mol. Aspects. Med. 29, 85-95.
6. Delpuech O, Trabut JB, Carnot F, Feuillard J, Brechot C, Kremsdorf D. (2002) Identification, using cDNA macroarray analysis, of distinct gene expression profiles associated with pathological and virological features of hepatocellular carcinoma. Oncogene 21, 2926-2937.
7. Dulak J, Funk H. (1996) Quantitative PCR in diagnostics of viral hepatitis C. Hepatol. Pol. 3, 31-39.
8. Eis PS, Tam W, Sun L, Chadburn A, Li Z, Gomez MF, Lund E, Dahlberg JE. (2005) Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc. Natl. Acad. Sci. USA 102, 3627-3632.
9. Gallegos-Orozco JF, Rakela J, Rosati MJ, Vargas HE, Balan V. (2008) Persistence of hepatitis C virus in peripheral blood mononuclear cells of sustained viral responders to pegylated interferon and ribavirin therapy. Dig. Dis. Sci. 53, 2564-2568.
10. Haasch D, Chen YW, Reilly RM, Chiou XG, Koterski S, Smith ML, Kroeger P, McWeeny K, Halbert DN, Mollison KW, Djuric SW, Trevillyan JM. (2002) T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the protooncogene, BIC. Cell. Immunol. 217, 78-86.
11. Henke JI, Goergen D, Zheng J, Song Y, Schüttler CG, Fehr C, Jünemann C, Niepmann M. (2008) microRNA-122 stimulates translation of hepatitis C virus RNA. EMBO J. 27, 3300-3310.
12. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P. (2005) Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309, 1577-1581.
13. Kluiver J, Poppema S, de Jong D, Blokzijl T, Harms G, Jacobs S, Kroesen BJ, van den Berg A. (2005) BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J. Pathol. 207, 243-249.
14. Lawrie CH, Soneji S, Marafioti T, Cooper CD, Palazzo S, Paterson JC, Cattan H, Enver T, Mager R, Boultwood J, Wainscoat JS, Hatton CS. (2007) MicroRNA expression distinguishes between germinal center B cell-like and activated B celllike subtypes of diffuse large B cell lymphoma. Int. J. Cancer 121, 1156-1161.
15. McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, Ling MH, Cort S, Albrecht JK. (1998) Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N. Engl. J. Med. 339, 1485-1492. doi:10.1056/NEJM199811193392101.
16. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D. (2007) MicroRNA-155 is induced during the macrophage inflammatory response. Proc. Natl. Acad. Sci. USA 104, 1604-1609.
17. Pedersen IM, Cheng G, Wieland S, Volinia S, Croce CM, Chisari FV, David M. (2007) Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 449, 919-922.
18. Pham TN, MacParland SA, Mulrooney PM, Cooksley H, Naoumov NV, Michalak TI. (2004) Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. J. Virol. 78, 5867-5874. doi:10.1128/JVI.78.11.5867-5874.2004.
19. Rahadiani N, Takakuwa T, Tresnasari K, Morii E, Aozasa K. (2008) Latent membrane protein-1 of Epstein-Barr virus induces the expression of B-cell integration cluster, a precursor form of microRNA-155, in B lymphoma cell lines. Biochem. Biophys. Res. Commun. 377, 579-83. doi:10.1016/.bbrc.2008.10.007.
20. Rai D, Karanti S, Jung I, Dahia PL, Aguiar RC. (2008) Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma. Cancer Genet. Cytogenet. 181, 8-15.
21. Sy T, Jamal MM. (2006) Epidemiology of hepatitis C virus (HCV) infection. Int. J. Med. Sci. 3, 41-46.
22. Teng G, Hakimpour P, Landgraf P, Rice A, Tuschl T, Casellas R, Papavasiliou FN. (2008) MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity 28, 621-629.
23. van den Berg A, Kroesen BJ, Kooistra K, de Jong D, Briggs J, Blokzijl T, Jacobs S, Kluiver J, Diepstra A, Maggio E, Poppema S. (2003) High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma. Genes Chromosomes Cancer 37, 20-28. doi:10.1002/gcc.10186.
24. Zignego AL, Giannini C, Caini P, Monti M, Gragnani L. (2007) Hepatitis C Virus lymphotropism lesion from a decade of studies. Dig. Liver Dis. 39, 38-45.